ポイントオブケア(PoC)診断の世界市場分析:製品別(グルコース試験、Hb1Ac試験、凝固、妊娠、心臓マーカー、感染症、プライマリーケアシステム、血液学、分化臨床化学、糞便、血液ガス電解質、外来化学、尿検査、薬物乱用検査)、エンドユーザー別(クリニック、病院、家庭、生活医療支援施設、研究所、緊急治療室)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Point of Care (PoC) Diagnostics Market Analysis By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Fertility, Cardiac Markers, Infectious Diseases, Primary Acre Systems, Hematology, Decentralized Clinical Chemistry, Feces, Blood Gas Electrolytes, Ambulatory Chemistry, Urinalysis, Drug Abuse Testing), By End-use (Clinics, Hospital, Home, Assisted Living Healthcare Facilities, Laboratory, Emergency Rooms) And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends& Scope
4.1 Market segmentation& scope
4.1.1 Market Driver Analysis
4.1.1.1 Introduction of CLIA waived tests
4.1.1.2 Increasing adoption of POC diagnostics
4.1.1.3 Growing demand for home healthcare and the introduction of advance technology enabled products
4.1.1.4 Growing geriatric population base
4.1.1.5 Growing prevalence of target diseases
4.1.2 Market Restraint Analysis
4.1.2.1 High procedure costs
4.1.2.2 Presence of ambiguous regulatory framework
4.2 Penetration & growth prospect mapping
4.3 Point of care diagnostics – SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis – Porter’s
4.5 Product ppsitioning Analysis
4.6 Price-cost-margin analysis for point-of-care devices
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
5.1 Point of care diagnostics market: Product movement analysis
5.2 Glucose testing
5.2.1 Glucose testing market, 2013 – 2024 (USD Million)
5.3 Hb1Ac Testing
5.3.1 Hb1Ac testing market, 2013 – 2024 (USD Million)
5.4 Coagulation testing
5.4.1 Coagulationtesting market, 2013 – 2024 (USD Million)
5.5 Fertility testing
5.5.1 Fertilty testing market, 2013 – 2024 (USD Million)
5.6 Cardiac markers
5.6.1 Cardiac markers market, 2013 – 2024 (USD Million)
5.7 Infectious disaese testing
5.7.1 Infectious disease testing market, 2013 – 2024 (USD Million)
5.8 Primary care systems
5.8.1 Primary care systemsmarket, 2013 – 2024 (USD Million)
5.9 Heamatology testing
5.9.1 Hematology testing market, 2013 – 2024 (USD Million)
5.10 Decentralized clinical chemistry
5.10.1 Decentralized clinical chemistry market, 2013 – 2024 (USD Million)
5.11 Blood gas/electrolytes testing
5.11.1 Blood gas/electrolytes testing market, 2013 – 2024 (USD Million)
5.12 Ambulatory chemistry
5.12.1 Ambulatory chemistry market, 2013 – 2024 (USD Million)
5.13 Urinanalysis
5.13.1 Urinanalysis market, 2013 – 2024 (USD Million)
5.14 Drug abuse testing
5.14.1 Drug abuse testing market, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization 3: End-use Estimates & Trend Analysis
6.1 Point of care diagnostics market:end-use movement analysis
6.2 Clinics
6.2.1 Clinics market, 2013 – 2024 (USD Million)
6.3 Hospitals
6.3.1 Hospitals market, 2013 – 2024 (USD Million)
6.4 Home
6.4.1 Home market, 2013 – 2024 (USD Million)
6.5 Assiated living healthcare facilities
6.5.1 Assiated living healthcare facilities market, 2013 – 2024 (USD Million)
6.6 Laboratories
6.6.1 Laboratories market, 2013 – 2024 (USD Million)
6.7 Others
6.7.1 Other end-use market, 2013 – 2024 (USD Million)
Chapter 7 Market Categorization 4: Regional Estimates & Trend Analysis, by Product, & End-use
7.1 Point of care diagnostics market share by region, 2015 & 2024
7.2 North America
7.2.1 North America point of care diagnostics market, 2013 – 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. point of care diagnostics market, 2013 – 2024 (USD Million)
7.2.3 Canada.
7.2.3.1 Canada point of care diagnostics market, 2013 – 2024 (USD Million)
7.3 Europe
7.3.1 Europe point of care diagnostics market, 2013 – 2024 (USD Million)
7.3.2 Germany
7.3.2.1 Germany point of care diagnostics market, 2013 – 2024 (USD Million)
7.3.3 France
7.3.3.1 Francepoint of care diagnostics market, 2013 – 2024 (USD Million)
7.3.4 Italy
7.3.4.1 Italy point of care diagnostics market, 2013 – 2024 (USD Million)
7.3.5 Spain
7.3.5.1 Spain point of care diagnostics market, 2013 – 2024 (USD Million)
7.3.6 UK.
7.3.6.1 UK point of care diagnostics market, 2013 – 2024 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific point of care diagnostics market, 2013 – 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan point of care diagnostics market, 2013 – 2024 (USD Million)
7.4.3 China.
7.4.3.1 China point of care diagnostics market, 2013 – 2024 (USD Million)
7.4.4 India
7.4.4.1 India point of care diagnostics market, 2013 – 2024 (USD Million)
7.4.5 Australia.
7.4.5.1 Australia point of care diagnostics market, 2013 – 2024 (USD Million)
7.4.6 Korea
7.4.6.1 Korea point of care diagnostics market, 2013 – 2024 (USD Million)
7.4.7 Singapore
7.4.7.1 India point of care diagnostics market, 2013 – 2024 (USD Million)
7.5 Latin America
7.5.1 Latin America point of care diagnostics market, 2013 – 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil point of care diagnostics market, 2013 – 2024 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico point of care diagnostics market, 2013 – 2024 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina point of care diagnostics market, 2013 – 2024 (USD Million)
7.5.5 Chile
7.5.5.1 Chile point of care diagnostics market, 2013 – 2024 (USD Million)
7.6 Middle East & Africa
7.6.1 Middle East & Africa point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.2 South Africa.
7.6.2.1 South Africa point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.3 Kenya
7.6.3.1 Kenya point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.4 Nigeria
7.6.4.1 Nigeria point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.5 Saudi Arabia.
7.6.5.1 Saudi Arabia point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.6 Zimbabwe
7.6.6.1 Zimbabwe point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.7 UAE
7.6.7.1 UAE point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.8 Qatar
7.6.8.1 Qatar point of care diagnostics market, 2013 – 2024 (USD Million)
7.6.9 Rest of MEA
7.6.9.1 Rest of MEA point of care diagnostics market, 2013 – 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.3 Company Profiles
8.3.1 Roche Diagnostics
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 Abbott Diagnostics Inc
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Siemens Healthcare
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Danaher Corporation (Beckman Coulter Inc. and Radiometer)
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 bioMerieux
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 Abaxis, Inc.
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 Alere, Inc.
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
8.3.8 Qiagen N.V.
8.3.8.1 Company Overview
8.3.8.2 Financial Performance
8.3.8.3 Product Benchmarking
8.3.8.4 Strategic Initiatives
8.3.9 Spectral Diagnostics
8.3.9.1 Company Overview
8.3.9.2 Financial Performance
8.3.9.3 Product Benchmarking
8.3.9.4 Strategic Initiatives
8.3.10 Instrumentation Laboratory
8.3.10.1 Company Overview
8.3.10.2 Financial Performance
8.3.10.3 Product Benchmarking
8.3.10.4 Strategic Initiatives
8.3.11 Johnson and Johnson
8.3.11.1 Company Overview
8.3.11.2 Financial Performance
8.3.11.3 Product Benchmarking
8.3.11.4 Strategic Initiatives
8.3.12 Nova Biomedical
8.3.12.1 Company Overview
8.3.12.2 Financial Performance
8.3.12.3 Product Benchmarking
8.3.12.4 Strategic Initiatives
8.3.13 Nipro Diagnostics Inc
8.3.13.1 Company Overview
8.3.13.2 Financial Performance
8.3.13.3 Product Benchmarking
8.3.13.4 Strategic Initiatives
8.3.14 HemoCue AB
8.3.14.1 Company Overview
8.3.14.2 Financial Performance
8.3.14.3 Product Benchmarking
8.3.14.4 Strategic Initiatives
8.3.15 International Technidyne Corporation (ITC)
8.3.15.1 Company Overview
8.3.15.2 Financial Performance
8.3.15.3 Product Benchmarking
8.3.15.4 Strategic Initiatives
8.3.16 Quidel Corporation
8.3.16.1 Company Overview
8.3.16.2 Financial Performance
8.3.16.3 Product Benchmarking
8.3.16.4 Strategic Initiatives
8.3.17 Trinity Biotech PLC
8.3.17.1 Company Overview
8.3.17.2 Financial Performance
8.3.17.3 Product Benchmarking
8.3.17.4 Strategic Initiatives
8.3.18 Sekisui Diagnostics LLC
8.3.18.1 Company Overview
8.3.18.2 Financial Performance
8.3.18.3 Product Benchmarking
8.3.18.4 Strategic Initiatives
8.3.19 OraSure Technologies Inc
8.3.19.1 Company Overview
8.3.19.2 Financial Performance
8.3.19.3 Product Benchmarking
8.3.19.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:ポイントオブケア(PoC)診断の世界市場分析:製品別(グルコース試験、Hb1Ac試験、凝固、妊娠、心臓マーカー、感染症、プライマリーケアシステム、血液学、分化臨床化学、糞便、血液ガス電解質、外来化学、尿検査、薬物乱用検査)、エンドユーザー別(クリニック、病院、家庭、生活医療支援施設、研究所、緊急治療室)、セグメント予測
■ 英文:Point of Care (PoC) Diagnostics Market Analysis By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Fertility, Cardiac Markers, Infectious Diseases, Primary Acre Systems, Hematology, Decentralized Clinical Chemistry, Feces, Blood Gas Electrolytes, Ambulatory Chemistry, Urinalysis, Drug Abuse Testing), By End-use (Clinics, Hospital, Home, Assisted Living Healthcare Facilities, Laboratory, Emergency Rooms) And Segment Forecasts To 2024
■ 発行日:2016年6月21日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707668
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。